Gene · 2817
Papers2,608
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,608
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress in Isolation and Molecular Profiling of Small Extracellular Vesicles via Bead-Assisted Platforms. | Biosensors (Basel) | 2023 | 37504087 | PubTator, text mining | PubMed |
| Targeting Glypican-1 Reverses Resistance to 5-Fluorouracil in Esophageal Adenocarcinoma Cells. | Anticancer Res | 2023 | 37500147 | PubTator, text mining | PubMed |
| N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope. | Cell Commun Signal | 2023 | 37480072 | PubTator, text mining | PubMed |
| Current status of molecular diagnostic approaches using liquid biopsy. | J Gastroenterol | 2023 | 37470859 | PubTator, text mining | PubMed |
| Graphene Sensor Arrays for Rapid and Accurate Detection of Pancreatic Cancer Exosomes in Patients' Blood Plasma Samples. | ACS Nano | 2023 | 37470391 | PubTator, text mining | PubMed |
| Identification of miRNAs in extracellular vesicles as potential diagnostic markers for pediatric epilepsy and drug-resistant epilepsy via bioinformatics analysis. | Front Pediatr | 2023 | 37469680 | PubTator, text mining | PubMed |
| Switching mechanism from AR to EGFR signaling via 3-O-sulfated heparan sulfate in castration-resistant prostate cancer. | Sci Rep | 2023 | 37463954 | PubTator, text mining | PubMed |
| Evolving utility of exosomes in pancreatic cancer management. | World J Methodol | 2023 | 37456979 | PubTator, text mining | PubMed |
| Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications. | Front Oncol | 2023 | 37456253 | PubTator, text mining | PubMed |
| Glycocalyx-Sodium Interaction in Vascular Endothelium. | Nutrients | 2023 | 37447199 | PubTator, text mining | PubMed |
| Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients. | Int J Mol Sci | 2023 | 37446098 | PubTator, text mining | PubMed |
| Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides. | Cells | 2023 | 37443733 | PubTator, text mining | PubMed |
| Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer. | Cancer Epidemiol Biomarkers Prev | 2023 | 37410084 | PubTator, text mining | PubMed |
| Advances in the Physiology of Transvascular Exchange and A New Look At Rational Fluid Prescription. | Int J Gen Med | 2023 | 37408844 | PubTator, text mining | PubMed |
| Emerging diversity in extracellular vesicles and their roles in cancer. | Front Oncol | 2023 | 37397375 | PubTator, text mining | PubMed |
| Persistent ER stress causes GPI anchor deficit to convert a GPI-anchored prion protein into pro-PrP via the ATF6-miR449c-5p-PIGV axis. | J Biol Chem | 2023 | 37390992 | PubTator, text mining | PubMed |
| Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice. | Int J Mol Sci | 2023 | 37373391 | PubTator, text mining | PubMed |
| Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets. | Cancers (Basel) | 2023 | 37370735 | PubTator, text mining | PubMed |
| Quantification of GPC1(+) Exosomes Based on MALDI-TOF MS In Situ Signal Amplification for Pancreatic Cancer Discrimination and Evaluation. | Anal Chem | 2023 | 37368911 | PubTator, text mining | PubMed |
| Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes. | Front Mol Biosci | 2023 | 37363401 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2817/papers?page=14